Abstract
Over the past 30 years, bone marrow transplantation has come to be accepted as standard curative therapy for many pathophysiologic conditions (Forman et al. 1994) including malignancies (Brenner et al. 1993) and metabolic diseases (Blaese 1993). Thus, the reconstitution of the hematopoietic system with normal allogeneic cells capable of providing long term engraftment with disease-free, physiologically functional cells has been used to treat various inherited diseases including severe combined immunodeficiency disease (SCID), lysosomal storage disorders and various hemoglobinopathies. However, difficulties in acquisition of histocompatible marrow cells for transplantation and onset of graft vs host disease has led to the continued search for better therapeutic strategies. Meanwhile, the delineation of the genetic bases of many inherited diseases and the subsequent isolation of appropriate wild-type genes promoted the feasibility of disease correction at the DNA level. To this end, much effort has focussed upon the development of both the identification of genetic strategies as well as efficient methods of delivery of therapeutic genes to appropriate target cells.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Alexander IE, Russell DW, Miller AD (1994) DNA-damaging agents greatly increase the transduction of nondividing cells by adeno-associated virus vectors. J Virol 68: 8282–8287
Baum CM, Weissman IL, Tsukamoto AS, Buckle AM, Peault B (1992) Isolation of a candidate human hematopoietic stem-cell population. Proc Natl Acad Sci USA 89: 2804–2808
Berns K, Pinkerton T, Thomas GF, Hoggan MN (1975) Detection of adeno-associated virus (AAV)-specific nucleotide sequences in DNA isolated from latently infected Detroit 6 cells. Virology 68: 556–560
Berns KI, Bohenzky RA (1987) Adeno-associated viruses: an update. Adv Virus Res 32: 243–306
Bertrand E, Carbonelle E, Lee NS, Zhou C, Kohn D, Good P, Engelke D, Chatterjee S, Rossi J (1996) Development of viral vectors for expression of ribozyme and antisense RNAs in mammalian cells. Nucleic Acids Res (submitted)
Beutler E (1993) Gaucher disease as a paradigm of current issues regarding single gene mutations of humans. Proc Natl Acad Sci USA 90: 5384–5390
Blaese RM (1993) Development of gene therapy for immunodeficiency: adenosine deaminase deficiency. Pediatr Res 33: S49
Brar D, Wong KK Jr, Permana P, Chatterjee S (1994) Promoter interactions in adeno-associated virus vectors encoding multiple gene cassettes: potential use in anti-oncogene vector design. Cancer Gene Ther 1: 321
Brenner MK, Rill DR, Holladay MS, Heslop HE, Moen RC, Buschle M, Krance RA, Santana VM, Anderson WF, Ihle JN (1993) Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patients. Lancet 342: 1134–1137
Buller RML, Janik J, Sebring ED, Rose JA (1981) Herpes simplex virus types 1 and 2 completely help adenovirus-associated virus replication. J Virol 40: 241–247
Carter RB, Abrams-Ogg AC, Dick JE, Kruth SA, Valli VE, Kamel-Reid S, Dube ID (1992) Autologous transplantation of canine long-term marrow culture cells genetically marked by retroviral vectors. Blood 79: 356
Challita PM, Kohn DB (1994) Lack of expression from a retroviral vector after transduction of murine hematopoietic stem cells is associated with methylation in vivo. Proc Natl Acad Sci USA 91: 2567–2571
Chatterjee S, Wong KK (1993) Adeno-associated virus vectors for the delivery of antisense RNA Methods (a companion to Methods in Enzymology) 5: 51–59
Chatterjee S, Johnson PR, Wong KK (1992) Dual target inhibition of HIV-1 in vitro with an adeno-associated virus-based antisense vector. Science 258: 1485–1488
Chatterjee S, Wong KK, Lu D, Permana P, Podsakoff GM (1995) Novel approaches for efficient gene transfer into hematopoietic progenitor cells: the use of adeno-associated virus vectors. Bone Marrow Transplant 15: 5309–5313
Dexter TM, Allen TD, Lajtha LG (1977) Conditions controlling the proliferation of haemopoietic stem cells in vitro. J Cell Physiol 91: 335–344
Dunbar CE, Cottier-Fox M, O’Shaughnessy JA, Doren S, Carter C, Berenson R, Brown S, Moen RC, Greenblatt J, Stewart FM, Leitman SF, Wilson WH, Cowan K, Young NS, Nienhuis AW (1995) Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation. Blood 85: 3048–3057
Fisher-Adams G, Wong KK, Podsakoff GM, Forman S, Chatterjee S (1996) Integration of adeno-associated virus vector genomes in human CD34 cells following transduction. Blood 88 (in press)
Flotte TR, Afione SA, Conrad C, McGrath SA, Solow R, Oka H, Zeitlin PL, Guggino WB, Carter BJ Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector. Proc Natl Acad Sci USA 90: 10613
Flotte TR, Afione SA, Zeitlin PL (1994) Adeno-associated virus vector gene expression occurs in nondividing cells in the absence of vector DNA integration. Am J Respir Cell Mol Biol 11: 517–521
Forman SJ, Blume KG, Thomas ED (eds) (1994) Bone marrow transplantation. Blackwell Scientific, Cambridge
Goodman S, Xiao X, Donahue RE, Moulton A, Miller J, Walsh C, Young NS, Samulski RJ, Nienhuis AW (1994) Recombinant adeno-associated virus-mediated gene transfer into hematopoietic progenitor cells. Blood 84: 1492–1500
Halbert CL, Alexander IE, Wolgamot GM, Miller AD (1995) Adeno-associated virus vectors transduce primary cells much less efficiently than immortalized cells. J Virol 69: 1473–1479
Janik JE, Huston MM, Rose JA (1981) Locations of adenovirus genes required for the replication of adeno-associated virus. Proc Natl Acad Sci USA 78: 1925–1930
Kantoff PW, Gillio AP, McKachlin JR, Bordignon C, Eglitis MA, Kernan NA, Moen RC, Kohn DB, Yu SF, Karson E, Karlsson S, Zwiebel JA, Gilboa E, Blaese RM, Nienhuis A, O’Reilly RJ, Anderson WF (1987) Expression of human adenosine deaminase in nonhuman primates after retrovirusmediated gene transfer. J Exp Med 166: 219–234
Kaplitt MG, Leone P, Samulski RJ, Xiao X, Pfaff DW, O’Malley KL, During MJ (1994) Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nature Genet 8: 148–153
Kotin RM, Siniscalco M, Samulski RJ, Zhu XD, Hunter L, Laughlin CA, Mclaughlin S, Muzyczka N, Rocchi M, Berns KI (1990) Site-specific integration by adeno-associated virus. Proc Natl Acad Sci USA 87: 2211–2215
Laughlin CA, Tratschin J-D, Coon H, Carter BJ (1983) Cloning of infectious adeno-associated virus genomes in bacterial plasmids. Gene 23: 65–73
Lebkowski JS, Mally MM, Okarma TB, Lerch LB (1988) Adeno-associated virus: a vector system for efficient introduction and integration of DNA into a variety of mammalian cell types. Mol Cell Biol 8: 3988–3996
Lu D, Chatterjee S, Brar D, Wong KK Jr (1994a) High efficiency in vitro cleavage of transcripts arising from the major transforming genes of human papillomavirus type 16 mediated by ribozymes transcribed from an adeno-associated virus-based vector. Cancer Gene Therapy. 1: 267–277
Lu D, Wong KK Jr, Podsakoff G, Chatterjee S (1994b) Stable and efficient adeno-associated virusmediated gene transfer into primitive human marrow-derived hematopoietic cells in long term culture. Blood 84 [Suppl 1]: 360a
Luskey BD, Rosenblatt M, Zsebo K, Williams DA (1992) Stem cell factor, interleukin-3, and interleukin-6 promote retroviral-mediated gene transfer into murine hematopoietic stem cells. Blood 80: 396–402
McLaughlin SK, Collis P, Hermonat PL, Muzyczka N (1988) Adeno-associated virus general transduction vectors: analysis of proviral structures. J Virol 62: 1963–1973
Miller AD (1990) Retrovirus packaging cells. Hum Gene Ther 1: 5–14
Miller DG, Adam MA, Miller AD (1990) Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol Cell Biol 10: 4239–4242
Miller AD, Miller DG, Garcia JV, Lynch CM (1993) Use of retroviral vectors for gene transfer and expression. Methods Enzymol 217: 581–599
Miller JL, Donahue RE, Sellers SE, Samulski RJ, Young NS, Nienhuis AW (1994) Recombinant adeno-associated virus (AV)-mediated expression of a human gamma-globin gene in human progenitorderived erythroid cells. Proc Natl Acad Sci USA 91: 10183–10187
Muzyczka N (1992) Use of AAV as a general transduction vector for mammalian cells. In: Muzyczka N (ed) Viral expression vectors. Springer, Berlin Heidelberg New York, pp 97–129 (Current topics in microbiology and immunology, vol 158)
Nolta JA, Crooks GM, Overell RW, Williams DE, Kohn DB (1992) Retroviral vector-mediated gene transfer into primitive human hematopoietic progenitor cells: effects of mast cell growth factor (MGF) combined with other cytokines. Exp Hematol 20: 1065–1071
Ogawa M (1993) Differentiation and proliferation of hematopoietic stem cells. Blood 81: 2844–2853
Podsakoff G, Wong KK Jr, Chatterjee S (1994a) Stable and efficient gene transfer into non-dividing cells by adeno-associated virus (AAV)-based vectors. J Virol 68: 656–5666
Podsakoff G, Shaughnessy EA, Lu D, Wong KK Jr, Chatterjee S (1994b) Long term in vivo reconstitution with murine marrow cells transduced with an adeno-associated virus vector. Blood 84 [Suppl]: 256a
Roe TY, Reynolds TC, Yu G, Brown PO (1993) Integration of murine leukemia virus DNA depends on mitosis. EMBO J 12: 2099–2108
Russell DW, Miller AD, Alexander IE (1994) Adeno-associated virus vectors preferentially transduce cells in S phase. Proc Natl Acad Sci USA 91: 8915–8919
Samulski RJ, Berns KI, Tan M, Muzyczka N (1982) Cloning of adeno-associated virus into PBR322: rescue of intact virus from recombinant plasmid in human cells. Proc Natl Acad Sci USA 79: 2077–2081
Samulski RJ, Chang L-S, Shenk T (1989) Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression. J Virol 63: 3822–3828
Samulski RJ, Zhu X, Xiao X, Brook JD, Housman DE, Epstein N, Hunter LA (1991) Targeted integration of adeno-associated virus (AAV) into human chromosome 19. EMBO J 10: 3941–3950
Sullenger BA, Gallardo HF, Ungers GE, Gilboa E (1990) Overexpression of TAR sequences renders cells resistant to human immunodeficiency virus replication. Cell 63: 601–608
Sutherland JH, Lansdorp PM, Kenkelman DH, Eaves AC, Eaves CJ (1990) Functional characterization of individual human hematopoietic stem cells cultured at limiting dilution on supportive marrow stormal layers. Proc Natl Acad Sci USA 87: 3584–3588
Sutherland HJ, Eaves CJ, Lansdorp PM, Thacker JD, Hogge DE (1991) Differential regulation of primitive human hematopoietic cells in long-term cultures maintained on genetically engineered murine stromal cells. Blood 78: 666–672
Walsh CE, Nienhuis AW, Samulski RJ, Brown MG, Miller JL, Young NS, Liu JM (1994) Phenotypic correction of Fanconi anemia in human hematopoietic cells with a recombinant adeno-associated virus vector. J Clin Invest 94: 1440–1448
Wong KK Jr, Rose JA, Chatterjee S (1991) Restriction of HSV-1 production in cell lines transduced with an antisense viral vector targeting the HSV-1 ICP4 gene. Vaccine 91: 183–189
Yu M, Poeschla E, Wong-Staal F (1994) Progress towards gene therapy for HIV infection. Gene Ther 1: 13–26
Zhou SZ, Broxmeyer HE, Cooper S, Harrington M, Srivastava A (1993) Adeno-associated virus 2-mediated gene transfer in murine hematopoietic progenitor cells. Exp Hematol 21: 928–933
Zhou SZ, Cooper S, Kang LY, Ruggieri L, Heimfeld S, Srivastava A, Broxmeyer HE (1994) Adeno-associated virus 2-mediated high efficiency gene transfer into immature and mature subsets of hematopoietic progenitor cells in human umbilical cord blood. J Exp Med 179: 1867–1875
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Chatterjee, S., Wong, K.K. (1996). Adeno-associated Virus Vectors for Gene Therapy of the Hematopoietic System. In: Berns, K.I., Giraud, C. (eds) Adeno-Associated Virus (AAV) Vectors in Gene Therapy. Current Topics in Microbiology and Immunology, vol 218. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-80207-2_5
Download citation
DOI: https://doi.org/10.1007/978-3-642-80207-2_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-80209-6
Online ISBN: 978-3-642-80207-2
eBook Packages: Springer Book Archive